Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ROCGU Stock Summary
In the News
ROCGU Financial details
Company Rating
Sell
Market Cap
57.89M
Income
-9.55M
Revenue
95.18M
Book val./share
0
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-50.85
Forward P/E
-
PEG
-0.56
P/S
-
P/B
1.01
P/C
-
P/FCF
-46.94
Quick Ratio
19.25
Current Ratio
0.2
Debt / Equity
0.54
LT Debt / Equity
0.52
-
-
EPS (TTM)
-0.54
EPS next Y
-
EPS next Q
-
EPS this Y
-99.81%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-45.95%
EPS Q/Q
-100.07%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
2.2%
Inst Trans
4.13%
ROA
-2%
ROE
-1%
ROC
-0.08%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.02-10.29
52W High
+2.9%
52W Low
+14.33%
RSI
-
Rel Volume
-
Avg Volume
-
Volume
2.42K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0%
Price
10.29
Change
14.08%
ROCGU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | -0.05 | -0.05 | 0 | |
Operating cash flow per share | 0 | 0 | -0.06 | -0.26 | 0 | |
Free cash flow per share | 0 | 0 | -0.06 | -0.26 | 0 | |
Cash per share | 0 | 0 | 0.11 | 7.42 | 0 | |
Book value per share | 0 | 0 | 16.03 | 7.19 | 0 | |
Tangible book value per share | 0 | 0 | 16.03 | 7.19 | 0 | |
Share holders equity per share | 0 | 0 | 16.03 | 7.19 | 0 | |
Interest debt per share | 0 | 0 | 0 | -0.49 | 0 | |
Market cap | 0 | 145.97M | 72.6M | 34.03M | 432.23B | |
Enterprise value | -25K | 145.95M | 71.8M | 33.94M | 0 | |
P/E ratio | 0 | -74.29K | -186.52 | -190.96 | -98.62K | |
Price to sales ratio | 0 | 0 | 0 | 0 | 2.98K | |
POCF ratio | 0 | -83.89K | -156.47 | -39.31 | -11.61K | |
PFCF ratio | 0 | -83.89K | -156.47 | -39.31 | -10.99K | |
P/B Ratio | 0 | 6.69K | 0.62 | 1.42 | 0 | |
PTB ratio | 0 | 6.69K | 0.62 | 1.42 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | -74.28K | -172.65 | -23.75 | 0 | |
EV to operating cash flow | 0 | -83.88K | -154.74 | -39.21 | 0 | |
EV to free cash flow | 0 | -83.88K | -154.74 | -39.21 | 0 | |
Earnings yield | 0 | 0 | -0.01 | -0.01 | 0 | |
Free cash flow yield | 0 | 0 | -0.01 | -0.03 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 11.6 | 1.93 | 0.06 | 0 | |
Current ratio | 20.41 | 15.72 | 4.05 | 0.35 | 0 | |
Interest coverage | 0 | 0 | 0 | 0.87 | -1.02 | |
Income quality | 0 | 0.89 | 1.15 | 4.86 | 37.83 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.2 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.07 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0.06 | |
Capex to revenue | 0 | 0 | 0 | 0 | -0.01 | |
Capex to depreciation | 0 | 0 | 0 | 0 | -1.91 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.03 | |
Graham number | 0 | 0 | 4.38 | 2.94 | 0 | |
ROIC | 0 | -0.09 | 0 | 0.05 | 0 | |
Return on tangible assets | 0 | -0.08 | 0 | -0.01 | 0 | |
Graham Net | 0 | 0 | 0.08 | 7.14 | 0 | |
Working capital | 23.78K | 21.34K | 746.43K | -688.24K | 0 | |
Tangible asset value | 23.78K | 21.81K | 117.59M | 23.99M | 0 | |
Net current asset value | 23.78K | 21.34K | 746.43K | -688.24K | 0 | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 67.72K | 0 | |
Average payables | 0 | 0 | 0 | 333.42K | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 170.31 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 2.14 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | -0.09 | 0 | -0.01 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 2.48 | 0.25 | 0 | |
Net income per share | -0.07 | -0.12 | -0.84 | 0.42 | 0 | |
Operating cash flow per share | -0.1 | -0.19 | -1.16 | 0.45 | 0 | |
Free cash flow per share | -0.1 | -0.19 | -1.16 | 0.45 | 0 | |
Cash per share | 0.03 | 7.41 | 2 | 0.54 | 0 | |
Book value per share | 7.19 | 7.07 | 1.1 | 1.11 | 0 | |
Tangible book value per share | 7.19 | 7.07 | 0.54 | 0.88 | 0 | |
Share holders equity per share | 7.19 | 7.07 | 1.1 | 1.11 | 0 | |
Interest debt per share | -0.34 | 0.02 | 1.14 | 0.51 | 0 | |
Market cap | 34.03M | 34.85M | 277.5M | 683.69M | 587.5B | |
Enterprise value | 33.94M | 34.93M | 295.8M | 713.61M | 587.52B | |
P/E ratio | -37.09 | -21.19 | -2.96 | 5.88 | -9.94K | |
Price to sales ratio | 0 | 0 | 4.03 | 39.97 | 63.55K | |
POCF ratio | -103.28 | -56.09 | -8.59 | 22.33 | -45.84K | |
PFCF ratio | -103.28 | -56.09 | -8.59 | 22.33 | -45.84K | |
P/B Ratio | 1.42 | 1.48 | 9.12 | 9.02 | 9.35K | |
PTB ratio | 1.42 | 1.48 | 9.12 | 9.02 | 9.35K | |
EV to sales | 0 | 0 | 4.3 | 41.72 | 63.55K | |
Enterprise value over EBITDA | -39.34 | -58.82 | 34.14 | -63.61 | -43.39K | |
EV to operating cash flow | -103.01 | -56.21 | -9.15 | 23.31 | -45.84K | |
EV to free cash flow | -103.01 | -56.21 | -9.15 | 23.31 | -45.84K | |
Earnings yield | -0.01 | -0.01 | -0.08 | 0.04 | 0 | |
Free cash flow yield | -0.01 | -0.02 | -0.12 | 0.04 | 0 | |
Debt to equity | 0 | 0.01 | 0.99 | 0.42 | 0.54 | |
Debt to assets | 0 | 0.01 | 0.15 | 0.22 | 0.27 | |
Net debt to EBITDA | 0.1 | -0.13 | 2.11 | -2.67 | -2.2 | |
Current ratio | 0.35 | 0.2 | 2.34 | 3.89 | 3.96 | |
Interest coverage | 0.77 | 4.94 | 5.46 | -3.9 | -4.71 | |
Income quality | 1.44 | 1.51 | 1.46 | 1.05 | 0.87 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0.14 | 0.43 | 0.89 | |
Research and developement to revenue | 0 | 0 | 0.04 | 0.14 | 0.26 | |
Intangibles to total assets | 0 | 0 | 0.08 | 0.11 | 0.11 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.07 | 0.18 | |
Graham number | 3.33 | 4.43 | 4.56 | 3.26 | 0 | |
ROIC | 0.11 | -0.03 | 0.1 | -0.07 | -0.14 | |
Return on tangible assets | -0.01 | -0.02 | -0.13 | 0.23 | -0.13 | |
Graham Net | -0.26 | 7.03 | -1.78 | 0.2 | 0 | |
Working capital | -688.24K | -1.02M | 89.36M | 87.11M | 78.29M | |
Tangible asset value | 23.99M | 23.58M | 15.03M | 60.49M | 48.42M | |
Net current asset value | -688.24K | -1.02M | -8.82M | 49.94M | 39.76M | |
Invested capital | 0 | 0.01 | 0.99 | 0.42 | 0.54 | |
Average receivables | 67.72K | 67.72K | 22.91M | 33.09M | 13.61M | |
Average payables | 410.23K | 807.67K | 27.53M | 36.81M | 17.59M | |
Average inventory | 0 | 0 | 25.32M | 54.04M | 59.42M | |
Days sales outstanding | 0 | 0 | 59.92 | 107.12 | 66.8 | |
Days payables outstanding | 48.08 | 143.77 | 113.49 | 135.51 | 221.64 | |
Days of inventory on hand | 0 | 0 | 106.19 | 399.3 | 867.65 | |
Receivables turnover | 0 | 0 | 1.5 | 0.84 | 1.35 | |
Payables turnover | 1.87 | 0.63 | 0.79 | 0.66 | 0.41 | |
Inventory turnover | 0 | 0 | 0.85 | 0.23 | 0.1 | |
ROE | -0.01 | -0.02 | -0.77 | 0.38 | -0.24 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ROCGU Frequently Asked Questions
What is Roth CH Acquisition IV Co. stock symbol ?
Roth CH Acquisition IV Co. is a US stock , located in Newport beach of Ca and trading under the symbol ROCGU
What is Roth CH Acquisition IV Co. stock quote today ?
Roth CH Acquisition IV Co. stock price is $10.29 today.
Is Roth CH Acquisition IV Co. stock public?
Yes, Roth CH Acquisition IV Co. is a publicly traded company.